Literature DB >> 206146

Abortive and productive infections of human mononuclear phagocytes by type I herpes simplex virus.

C A Daniels, E S Kleinerman, R Snyderman.   

Abstract

The ability of Type I herpes simplex (HSV) to replicate in normal human monouclear phagocytes was investigated. Mononuclear leukocytes were obtained from the peripheral blood of patients by Ficoll-Hypaque gradient centrifugation, and the monocytes were isolated by allowing the cells to adhere to tissue culture dishes. The monocytes (10(5.0) cells) were infected (10(7.0) PFU HSV) either immediately after isolation or were cultured in vitro for varying numbers of days and were then infected. Inoculation of freshly isolated monocytes resulted primarily in an abortive infection. HSV antigens were produced by the cells, as determined by a indirect fluorescent antibody technique, and empty herpes capsid structures were detected by electron microscopy of the inoculated monocytes; however, no increase in virus titer was noted in the cultures. Inoculation of viable cells that had been maintained for 7 days in culture resulted in a productive infection. An increase in titer was noted 24 hours after inoculation, and normal virus maturation was documented by ultrastructural study of the infected cells. The experiments show that the interaction of HSV with human mononuclear phagocytes is complex, and the data suggest that whether or not the cell replicates infectious virus may depend on the functional activity of the cell.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 206146      PMCID: PMC2018167     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  20 in total

Review 1.  ASPECTS OF THE PATHOGENESIS OF VIRUS DISEASES.

Authors:  C A MIMS
Journal:  Bacteriol Rev       Date:  1964-03

2.  ANTIGENIC ANALYSIS OF HERPES SIMPLEX VIRUS BY NEUTRALIZATION KINETICS.

Authors:  W K ASHE; H W SCHERP
Journal:  J Immunol       Date:  1963-11       Impact factor: 5.422

3.  Study of the mechanism of innate resistance to virus infection.

Authors:  G T GOODMAN; H KOPROWSKI
Journal:  J Cell Comp Physiol       Date:  1962-06

4.  MOUSE MACROPHAGES AS HOST CELLS FOR THE MOUSE HEPATITIS VIRUS AND THE GENETIC BASIS OF THEIR SUSCEPTIBILITY.

Authors:  F B Bang; A Warwick
Journal:  Proc Natl Acad Sci U S A       Date:  1960-08       Impact factor: 11.205

5.  Mechanism of the restricted growth of herpes simplex virus type 2 in a hamster cell line.

Authors:  J J Docherty; R A Mäntyjärvi; F Rapp
Journal:  J Gen Virol       Date:  1972-09       Impact factor: 3.891

6.  Depression of human monocyte chemotaxis by herpes simplex and influenza viruses.

Authors:  E S Kleinerman; R Snyderman; C A Daniels
Journal:  J Immunol       Date:  1974-11       Impact factor: 5.422

7.  Electron microscopy of herpes simplex virus. 3. Effect of hydroxyurea.

Authors:  S Nii; H S Rosenkranz; C Morgan; H M Rose
Journal:  J Virol       Date:  1968-10       Impact factor: 5.103

8.  Heterogeneity in the properties of 7 S and 19S rabbit-neutralizing antibodies to herpes simplex virus.

Authors:  B Hampar; A L Notkins; M Mage; M A Keehn
Journal:  J Immunol       Date:  1968-03       Impact factor: 5.422

9.  Human monocyte-macrophage-mediated antibody-dependent cytotoxicity to herpes simplex virus-infected cells.

Authors:  S Kohl; S E Starr; J M oleske; S L Shore; R B Ashman; A J Nahmias
Journal:  J Immunol       Date:  1977-03       Impact factor: 5.422

10.  THE PATHOGENESIS OF HERPES VIRUS ENCEPHALITIS. II. A CELLULAR BASIS FOR THE DEVELOPMENT OF RESISTANCE WITH AGE.

Authors:  R T JOHNSON
Journal:  J Exp Med       Date:  1964-09-01       Impact factor: 14.307

View more
  17 in total

1.  Replication of herpes simplex virus type 1 in macrophages from resistant and susceptible mice.

Authors:  C Lopez; G Dudas
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

2.  Permissiveness of rabbit monocytes and macrophages for herpes simplex virus type 1.

Authors:  S Plaeger-Marshall; L A Wilson; J W Smith
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

3.  Different susceptibilities of skin to type 1 and type 2 herpes simplex viruses in newborn rabbits.

Authors:  J O Oh; P Minasi
Journal:  Infect Immun       Date:  1980-01       Impact factor: 3.441

4.  Regulation of human monocyte/macrophage function by extracellular matrix. Adherence of monocytes to collagen matrices enhances phagocytosis of opsonized bacteria by activation of complement receptors and enhancement of Fc receptor function.

Authors:  S L Newman; M A Tucci
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

5.  Measles virus infection of unstimulated blood mononuclear cells in vitro: antigen expression and virus production preferentially in monocytes.

Authors:  R Salonen; J Ilonen; A Salmi
Journal:  Clin Exp Immunol       Date:  1988-02       Impact factor: 4.330

6.  Inhibition of intracellular growth of Histoplasma capsulatum yeast cells by cytokine-activated human monocytes and macrophages.

Authors:  S L Newman; L Gootee; C Bucher; W E Bullock
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

7.  Replication of rubella virus in human mononuclear blood cells.

Authors:  J T van der Logt; A M van Loon; J van der Veen
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

8.  Replication of virulent and attenuated strains of yellow fever virus in human monocytes and macrophage-like cells (U937).

Authors:  F Liprandi; R Walder
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

9.  Hydrogen peroxide metabolism in human monocytes during differentiation in vitro.

Authors:  A Nakagawara; C F Nathan; Z A Cohn
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

10.  Both plasmacytoid dendritic cells and monocytes stimulate natural killer cells early during human herpes simplex virus type 1 infections.

Authors:  Karin Vogel; Sabrina Thomann; Benjamin Vogel; Philipp Schuster; Barbara Schmidt
Journal:  Immunology       Date:  2014-12       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.